Feasibility study of the simultaneous integrated boost (SIB) method for malignant gliomas using intensity-modulated radiotherapy (IMRT)

Japanese Journal of Clinical Oncology

Volumn 33, Issue 6, 2003, Pages 271-277

  Suzuki, Minoru ^a,b   Nakamatsu, Kiyoshi ^a   Kanamori, Shuichi ^a   Okumra, Masahiko ^a   Uchiyama, Takuya ^a   Akai, Fumiharu ^a   Nishimura, Yasumasa ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Feasibility study; Intensity modulated radiotherapy; Malignant glioma; Simultaneous integrated boost

Indexed keywords

BETA INTERFERON; NIMUSTINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DEATH; EDEMA; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; RADIATION DERMATITIS; RADIATION DOSE; RADIATION SICKNESS; RECURRENT CANCER; TREATMENT OUTCOME; TUMOR VOLUME; CENTRAL NERVOUS SYSTEM TUMOR; COMPUTER ASSISTED RADIOTHERAPY; GLIOMA; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

AGED; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEASIBILITY STUDIES; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 0042785861     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyg053     Document Type: Article

References (26)

1. Nakagawa K, Aoki Y, Fujimaki T, Tago M, Terahara A, Karasawa K, et al. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998;40:1141-9.
2. Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M. 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol 1999;53:53-7.
3. Lee SW, Fraass BA, Marsh LH, Herbort K, Gebarski SS, Martel MK, et al. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: A quantitative dosimetric study. Int J Radiat Oncol Biol Phys 1999;43:79-88.
4. Levin VA, Yung WKA, Bruner J, Kyritsis A, Leeds N, Gleason MJ, et al. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic glioma. Int J Radiat Oncol Biol Phys 2002;53:58-66.
5. Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR. et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 2002;20:1635-42.
6. Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002;53:12-22.
7. Benedict SH, Cardinale RM, Wu Q, Zweicker RD, Broaddus WC, Mohan R. Intensity-modulated stereotactic radiosurgery using dynamic micromultileaf collimation. Int J Radiat Oncol Biol Phys 2001;50:751-8.
8. Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, et al. High-dose intensity-modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002;53:1111-6.
9. International Commission on Radiation Units and Measurements (ICRU). Report Number 50: Prescribing, Recording and Reporting Photon Beam Therapy. Washington, DC: ICRU 1993.
10. Khoo VS, Oldham M, Adams EJ, Bedford JL, Webb S, Brada M. Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors. Int J Radiat Oncol Biol Phys 1999;45:415-25.
11. Hunt MA, Hsiung CY, Spirou SV, Chui CS, Amols HI, Ling CC. Evaluation of concave dose distributions created using an inverse planning system. Int J Radiat Oncol Biol Phys 2002;54:953-62.
12. IMRT CWG: Intensity-modulateC radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 2001;51:880-914.
13. Chui CS, Spirou S, LoSasso T. Testing of dynamic multileaf collimation. Med Phys 1996;23:635-41.
14. Zhu TC, Ding CR, Liu CR, Palta JR. Simon WE, Shi J. Performance evaluation of a diode array for enhanced dynamic wedge dosimetiy. Med Phys 1997;24:1173-80.
15. Bentzen SM, Overgaard J, Thames HD, Overgaard M, Hansen PV, von der Maase H, et al. Clinical radiobiology of malignant melanoma. Radiother Oncol 1989;16:169-82.
16. Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 2002;52:6-13.
17. Raaphorst GP, Feeley MM, Da Silva VF, Danjoux CE, Gerig LH. A comparison of heat and radiation sensitivity of three human glioma cell lines. Int J Radiat Oncol Biol Phys 1989;17:615-22.
18. Hasegawa M, Niibe H, Mitsuhashi N, Yamakawa M, Kato S, Furuta M, et al. Hyperfractionated and hypofractionated radiation therapy for human malignant glioma xenograft in nude mice. Jpn J Cancer Res 1995;86:879-84.
19. Tamura M, Nakamura M, Kunimae H, Ono N, Zama A, Hayakawa K, et al. Large dose fraction radiotherapy in the treatment of gioblastoma. J Neuro-Oncol 1989;7:113-9.
20. Brada M, Thomas G, Elyan S, James N, Hines H, Ashley S, et al. Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: Accelerated radiotherapy in high-grade astrocytoma. Br J Cancer 1995;71:1330-4.
21. Shibamoto Y, Nishimura Y, Tsutsui K, Sasai K, Takahashi M, Abe M. Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma. Jpn J Clin Oncol 1997;27:31-6.
22. Lutterbach J, Weigel P, Guttenberger R, Hinkelbein W. Accelerated hyperfractionated radiotherapy in 149 patients with glioblastoma multiforme. Radiother Oncol 1999;53:49-52.
23. Corn BW, Yousen DM, Scott CB, Rotman M, Asbell SO, Nelson DF, et al. White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02). Cancer 1994;74: 2828-35.
24. Sneed PK, Larson DA, Gutin PH. Brachytherapy and hyperthermia for malignant astrocytomas. Semin Oncol 1994;21:186-97.
25. Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;51:571-8.
26. Suwinski R, Sowa A, Rutkowski T, Wydmanski J, Tarnawski R, Maciejewski BJ. Time factor in postoperative radiotherapy: A multivariate locoregional control analysis in 868 patients. Int J Radiat Oncol Biol Phys 2003;56:399-412.